Neuroone Medical Technologies (NMTC) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Neuroone Medical Technologies (NMTC) over the last 11 years, with Q4 2025 value amounting to $50.4 million.
- Neuroone Medical Technologies' Shares Outstanding rose 6345.71% to $50.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $50.4 million, marking a year-over-year increase of 6345.71%. This contributed to the annual value of $50.0 million for FY2025, which is 6227.17% up from last year.
- Per Neuroone Medical Technologies' latest filing, its Shares Outstanding stood at $50.4 million for Q4 2025, which was up 6345.71% from $50.0 million recorded in Q3 2025.
- Over the past 5 years, Neuroone Medical Technologies' Shares Outstanding peaked at $50.4 million during Q4 2025, and registered a low of $11.9 million during Q1 2021.
- Over the past 5 years, Neuroone Medical Technologies' median Shares Outstanding value was $20.9 million (recorded in 2023), while the average stood at $24.9 million.
- In the last 5 years, Neuroone Medical Technologies' Shares Outstanding surged by 11031.64% in 2021 and then skyrocketed by 31.35% in 2022.
- Neuroone Medical Technologies' Shares Outstanding (Quarter) stood at $16.2 million in 2021, then increased by 0.31% to $16.2 million in 2022, then skyrocketed by 52.92% to $24.8 million in 2023, then rose by 24.21% to $30.8 million in 2024, then skyrocketed by 63.46% to $50.4 million in 2025.
- Its Shares Outstanding stands at $50.4 million for Q4 2025, versus $50.0 million for Q3 2025 and $49.8 million for Q2 2025.